Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics is discovering and developing the next generation of cancer immunotherapies, offering the promise of safer, more efficacious therapeutics
Raised
$30M
Follow us
Alexa global traffic share
Twitter followers
27 Sep 2018
$30,000,000
Venture capital (Series A)

Akrevia Therapeutics Raises $30M in Series A Financing

FinSMEs
+3